Literature DB >> 32569976

Nuclear receptors in osteoclasts.

Seyeon Bae1, Steven Zeng2, Kyung-Hyun Park-Min3.   

Abstract

Osteoclasts are bone-resorbing cells that play an essential role in the remodeling of bone under physiological conditions and numerous pathological conditions, such as osteoporosis, bone metastasis, and inflammatory bone erosion. Nuclear receptors are crucial to various physiological processes, including metabolism, development and inflammation, and function as transcription factors to activate target genes. Synthetic ligands of nuclear receptors are also available for the treatment of metabolic and inflammatory diseases. However, dysregulated bone phenotypes have been documented in patients who take synthetic nuclear receptor ligands as a therapy. Therefore, the effect of nuclear receptors on bone cells has become an important area of exploration; additionally, the molecular mechanisms underlying the action of nuclear receptors in osteoclasts have not been completely understood. Here, we cover the recent progress in our understanding of the roles of nuclear receptors in osteoclasts.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2020        PMID: 32569976      PMCID: PMC7669703          DOI: 10.1016/j.coph.2020.03.002

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  112 in total

Review 1.  Estrogen and the skeleton.

Authors:  Sundeep Khosla; Merry Jo Oursler; David G Monroe
Journal:  Trends Endocrinol Metab       Date:  2012-05-16       Impact factor: 12.015

Review 2.  Oestrogen-related receptors in breast cancer: control of cellular metabolism and beyond.

Authors:  Geneviève Deblois; Vincent Giguère
Journal:  Nat Rev Cancer       Date:  2012-11-29       Impact factor: 60.716

3.  Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Authors:  W S Simonet; D L Lacey; C R Dunstan; M Kelley; M S Chang; R Lüthy; H Q Nguyen; S Wooden; L Bennett; T Boone; G Shimamoto; M DeRose; R Elliott; A Colombero; H L Tan; G Trail; J Sullivan; E Davy; N Bucay; L Renshaw-Gegg; T M Hughes; D Hill; W Pattison; P Campbell; S Sander; G Van; J Tarpley; P Derby; R Lee; W J Boyle
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

4.  Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes.

Authors:  Nick Z Lu; John A Cidlowski
Journal:  Mol Cell       Date:  2005-04-29       Impact factor: 17.970

5.  Secreted frizzled-related protein 1 modulates glucocorticoid attenuation of osteogenic activities and bone mass.

Authors:  Feng-Sheng Wang; Chun-Liang Lin; Yeung-Jen Chen; Ching-Jen Wang; Kuender D Yang; Yu-Ting Huang; Yi-Chih Sun; Hui-Chen Huang
Journal:  Endocrinology       Date:  2005-01-27       Impact factor: 4.736

Review 6.  Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system.

Authors:  Sakae Tanaka; Kozo Nakamura; Naoyuki Takahasi; Tatsuo Suda
Journal:  Immunol Rev       Date:  2005-12       Impact factor: 12.988

7.  Activation of the liver X receptor-β potently inhibits osteoclastogenesis from lipopolysaccharide-exposed bone marrow-derived macrophages.

Authors:  Kirsten M Robertson Remen; Ulf H Lerner; Jan-Åke Gustafsson; Göran Andersson
Journal:  J Leukoc Biol       Date:  2012-10-25       Impact factor: 4.962

8.  Absence of estrogen receptor-related-alpha increases osteoblastic differentiation and cancellous bone mineral density.

Authors:  I Delhon; S Gutzwiller; F Morvan; S Rangwala; L Wyder; G Evans; A Studer; M Kneissel; B Fournier
Journal:  Endocrinology       Date:  2009-07-16       Impact factor: 4.736

9.  Ligand Activation of ERRα by Cholesterol Mediates Statin and Bisphosphonate Effects.

Authors:  Wei Wei; Adam G Schwaid; Xueqian Wang; Xunde Wang; Shili Chen; Qian Chu; Alan Saghatelian; Yihong Wan
Journal:  Cell Metab       Date:  2016-01-14       Impact factor: 27.287

Review 10.  Postmenopausal hormone replacement therapy: scientific review.

Authors:  Heidi D Nelson; Linda L Humphrey; Peggy Nygren; Steven M Teutsch; Janet D Allan
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

View more
  1 in total

Review 1.  The Crossroads between Infection and Bone Loss.

Authors:  Tiago Carvalho Oliveira; Maria Salomé Gomes; Ana Cordeiro Gomes
Journal:  Microorganisms       Date:  2020-11-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.